the prohibition and restriction of the use of four types of plastic
Fosun Pharma’s MEK1/2 inhibitor initiates phase II clinical treatment for type I neurofibromas
Innovent's GLP-1R/GCGR dual agonist treatment of type 2 diabetes phase Ib clinical results announced
GZR18, a US subsidiary of Ganli Pharmaceuticals, was approved by the FDA for its clinical trial for the treatment of type 2 diabetes
Innovative combination of RNA activation therapy for first-line treatment of advanced liver cancer enters the clinic
Three types of imitation inhalants of Jiming Trust are accepted by CDE
Aurora A Small Molecule Oral Inhibitor Approved for Clinical Trial in China
Chinese scholar Science's latest article: unique double-stranded RNA synthesis mechanism
Zhou Yufeng’s team first revealed the function and regulatory mechanism of circular RNA in allergic
of the 4 types of flurbiprofen gel plaster reported for production
Chen Lingling's team: The immunogenicity and potential applications of in vitro synthesized circular RNA, a conversation scientist at Cell Press
Cysteinyl leukotriene and IL-25 produced by clustered cells synergistically initiate lung type 2 inflammation
Studies have discovered the immunogenic mechanism of in vitro synthesis of circular RNA and its potential applications
Chen Lingling's group discovered the immunogenic mechanism and potential applications of in vitro synthesis of circular RNA
There are 5 types of APS-related cardiovascular diseases!
Hit the first domestic RNA therapy!
the results of the first Chinese pancreatic cancer cohort driven copy number variation-driven molecular typing study
Ruige Pharmaceutical's new generation of CDK2/4/6 small molecule inhibitors received clinical approval in the U.S.
The National Nano Center and others have made progress in the research of all-small molecule organic solar cells
This type of fungal infectious disease with a very high fatality rate ushered in new oral drugs